Story Navigation
-
Access to HealthcareAccess to HealthcareFuture of HealthcareLocal ImpactSocial CommitmentBeacon of Hope lights the way for a more equitable future
Sharing Key Insights and Lessons to Accelerate Progress.
Access to Healthcare -
People and CultureCareersWorking at NovartisBelonging here: How Novartis helped me come out as a transgender womanPeople and Culture
-
People and CultureCareersWomen in ScienceWorking at NovartisMentoring matters: how we grow together at NovartisPeople and Culture
-
DiscoveryCancerDrug DevelopmentOncologyReimagine MedicineTreatments for blood cancers and serious blood disorders are advancing rapidly – Novartis is helping lead the way
Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.
Discovery -
Live MagazineFuture of HealthcareInnovationMedical InnovationsReimagine MedicineScientific DiscoveriesThe future of medicine is here
An essay by Vas Narasimhan, CEO of Novartis about the historical context and coming innovations in medicine with an introduction by Goran Mijuk.
Live Magazine -
Patient PerspectivesDisease AwarenessDiseasesLiving With DiseasePatient EducationRare DiseasesQ&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
Hear from Director of Patient Services at AAMDSIF on how she supports patients with PNH, a blood disorder that significantly impacts quality of life.
Patient Perspectives -
Patient PerspectivesCancerDisease AwarenessLiving With DiseaseOncologyWhen you think of the word ‘cancer’, what are the first words that spring to mind?
Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?
Patient Perspectives -
Access to HealthcareIn Colombia, a researcher works against a devastating disease
Alexandra Cossio Duque, a clinical and community research coordinator from Colombia, has travelled the world to study how to overcome social and geographic barriers to healthcare access. Today, she is working in her home country to strengthen the capacity of health systems to treat leishmaniasis, a neglected tropical disease that is endemic to rural areas of Colombia.
Access to Healthcare -
DiscoveryEmpowering the next generation of healthcare leaders
As part of the Beacon of Hope initiative, the Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts, US, offers 10-week paid summer fellowships for students at Historically Black Medical Schools to gain experience in drug discovery, data analytics and clinical research practices - with the goal of training up to 250 scientific leaders over 10 years.
Discovery -
Access to HealthcareGoing upstream to improve heart health in Philadelphia
Cardiovascular disease is the leading cause of death in the US, claiming one in four lives. Social factors such as living conditions, education and diet play a key role in determining a person’s heart health, which means cardiovascular disease typically hits vulnerable communities the hardest. Our three-year Closing the Gap initiative with the Jefferson Collaborative for Health Equity (established by Jefferson Health and Thomas Jefferson University) focuses on addressing the upstream social determinants of heart health in five vulnerable neighborhoods in Philadelphia with high rates of stroke and adverse outcomes related to heart disease.
Access to Healthcare -
Patient PerspectivesA cancer patient gets a new lease on life
After being diagnosed with advanced prostate cancer, Van Lacour received a Novartis radioligand therapy as part of a managed access program in 2021. Today, he is living a fulfilling life in his hometown of Natchez, Louisiana, US.
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchEthical BusinessMedicine SafetyCompassionate use: Providing access to much needed treatments
What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.
Access to Healthcare
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 32
- › Next page